Total Payments
$1,467
2023 Payments
$107.02
Companies
13
Transactions
34
Medicare Patients
894
Medicare Billing
$85,284
Payment Breakdown by Category
Food & Beverage$1,399 (95.3%)
Other$68.75 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,399 | 30 | 95.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68.75 | 4 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $345.28 | 10 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $332.88 | 5 | $0 (2023) |
| UCB, Inc. | $284.03 | 4 | $0 (2020) |
| Allergan Inc. | $124.99 | 1 | $0 (2019) |
| Adamas Pharmaceuticals, Inc. | $120.35 | 1 | $0 (2020) |
| Acorda Therapeutics, Inc | $68.75 | 4 | $0 (2019) |
| EMD Serono, Inc. | $41.37 | 1 | $0 (2019) |
| CSL Behring | $38.18 | 3 | $0 (2020) |
| ABBVIE INC. | $29.02 | 1 | $0 (2022) |
| Kyowa Kirin, Inc. | $23.29 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $107.02 | 1 | Alexion Pharmaceuticals, Inc. ($107.02) |
| 2022 | $152.70 | 4 | Alexion Pharmaceuticals, Inc. ($83.06) |
| 2021 | $23.29 | 1 | Kyowa Kirin, Inc. ($23.29) |
| 2020 | $173.50 | 4 | Adamas Pharmaceuticals, Inc. ($120.35) |
| 2019 | $721.69 | 18 | UCB, Inc. ($265.35) |
| 2018 | $289.18 | 6 | Genentech USA, Inc. ($289.18) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $107.02 | General |
| Category: Rare Disease | ||||||
| 11/16/2022 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: NEUROLOGY | ||||||
| 09/29/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $83.06 | General |
| Category: Rare Disease | ||||||
| 09/12/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/14/2022 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Neurology | ||||||
| 10/20/2021 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 03/04/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Neuroscience | ||||||
| 02/25/2020 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Immunology | ||||||
| 01/21/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $120.35 | General |
| Category: PD | ||||||
| 01/14/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Neurology | ||||||
| 12/03/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $113.09 | General |
| 11/13/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: Immunology | ||||||
| 11/11/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology | ||||||
| 11/06/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neurology | ||||||
| 10/07/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Immunology | ||||||
| 10/03/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $41.37 | General |
| Category: Neurology | ||||||
| 10/02/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $23.03 | General |
| Category: PARKINSONS DISEASE | ||||||
| 09/23/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2019 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Immunology | ||||||
| 07/24/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 06/19/2019 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Immunology | ||||||
| 05/21/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Neurology | ||||||
| 04/24/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $18.35 | General |
| Category: PARKINSONS DISEASE | ||||||
| 04/17/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15.34 | General |
| Category: PARKINSONS DISEASE | ||||||
| 04/08/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12.03 | General |
| Category: PARKINSONS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 477 | 586 | $268,989 | $42,678 |
| 2022 | 8 | 290 | 499 | $73,027 | $31,617 |
| 2021 | 6 | 127 | 149 | $24,638 | $10,989 |
Total Patients
894
Total Services
1,234
Medicare Billing
$85,284
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 104 | 104 | $40,986 | $14,520 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 76 | 96 | $21,825 | $9,559 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 62 | $9,838 | $4,275 | 43.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 63 | 81 | $26,898 | $2,776 | 10.3% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 38 | 38 | $50,471 | $2,200 | 4.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 24 | 24 | $49,878 | $1,913 | 3.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 30 | $14,160 | $1,874 | 13.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 20 | $14,080 | $1,691 | 12.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $11,245 | $1,335 | 11.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 28 | 40 | $7,831 | $931.86 | 11.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 39 | 63 | $10,386 | $893.60 | 8.6% |
| 95908 | Nerve conduction, 3-4 studies | Facility | 2023 | 15 | 15 | $11,391 | $709.72 | 6.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 91 | 178 | $37,914 | $17,487 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 34 | 34 | $10,914 | $4,115 | 37.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 61 | 151 | $7,852 | $3,356 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 40 | $6,040 | $2,930 | 48.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 28 | 41 | $3,690 | $1,339 | 36.3% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 14 | 14 | $2,940 | $1,123 | 38.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 18 | 18 | $2,826 | $957.84 | 33.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 13 | 23 | $851.00 | $308.90 | 36.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 32 | 44 | $9,372 | $4,761 | 50.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 23 | 23 | $7,383 | $3,161 | 42.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 32 | 39 | $3,510 | $1,365 | 38.9% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 13 | 13 | $2,041 | $793.78 | 38.9% |
| 95908 | Nerve transmission studies, 3-4 studies | Facility | 2021 | 13 | 13 | $1,703 | $664.82 | 39.0% |
About Dr. Dustin Smyth, DO
Dr. Dustin Smyth, DO is a Neurology healthcare provider based in Scarborough, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1457705568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dustin Smyth, DO has received a total of $1,467 in payments from pharmaceutical and medical device companies, with $107.02 received in 2023. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,399).
As a Medicare-enrolled provider, Smyth has provided services to 894 Medicare beneficiaries, totaling 1,234 services with total Medicare billing of $85,284. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Scarborough, ME
- Active Since 04/15/2016
- Last Updated 04/01/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457705568
Products in Payments
- Briviact (Drug) $284.03
- OCREVUS (Biological) $220.04
- ULTOMIRIS (Biological) $190.08
- BOTOX (Drug) $124.99
- GOCOVRI (Drug) $120.35
- INBRIJA (Drug) $68.75
- Mavenclad (Biological) $41.37
- Hizentra (Biological) $38.18
- SOLIRIS (Drug) $29.71
- BOTOX (Biological) $29.02
- NOURIANZ (Drug) $23.29
- EPIDIOLEX (Drug) $20.36
- XCOPRI (Drug) $20.26
- Aimovig (Biological) $18.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Scarborough
Heidi Henninger, Md, MD
Neurology — Payments: $245,819
Neurology $245,819
Edward Drasby, D.o, D.O
Neurology — Payments: $152,686
Neurology $152,686
Dr. Helia Maghzi, Md, MD
Neurology — Payments: $36,321
Neurology $36,321
Michael Kleinman, Do, DO
Neurology — Payments: $11,025
Neurology $11,025
Christine Lu-Emerson, M.d, M.D
Neurology — Payments: $4,510
Neurology $4,510
Biljana Beretich, Md, MD
Neurology — Payments: $3,497
Neurology $3,497